HONG KONG, Sept. 1, 2026 — H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $75 billion of capital under management, is pleased to announce that Younghee Choi has joined the firm’s Capital Formation Group as Head of Asia. Younghee is based in Hong Kong and will lead capital formation efforts across Asia for H.I.G.’s global private equity, credit, and real assets platforms.

With more than 15 years of experience in capital formation and private markets, Younghee joins H.I.G. from Blackstone, where she held senior roles across the firm’s Institutional Client Solutions (“ICS”) and Private Wealth businesses, serving as Senior Managing Director and Head of Korea ICS. During her tenure at Blackstone, Younghee developed and expanded relationships with a broad base of leading institutional investors and played a key role in building the firm’s private wealth fundraising business in Korea.

Jordan Peer Griffin, Executive Managing Director and Global Head of the Capital Formation Group, commented: “We are pleased to welcome Younghee to H.I.G. Her extensive capital formation experience, longstanding relationships across Asia, and ability to build enduring partnerships with institutional and private wealth investors will further strengthen our presence in the region. Younghee’s leadership will be instrumental as we expand our Asian LP base and support the continued growth of H.I.G.’s global investment platforms.”

Younghee Choi, Head of Asia, also commented: “I am thrilled to join H.I.G. at such an exciting time in the firm’s growth. I look forward to working closely with the team to deepen our relationships with investors across Asia, broaden H.I.G.’s presence in the region, and connect our investors with the full breadth of the firm’s global capabilities.”

About H.I.G. Capital

H.I.G. is a leading global alternative investment firm with $75 billion of capital under management.* Based in Miami, and with offices in Atlanta, Boston, Chicago, Los Angeles, New York, San Francisco, and Stamford in the United States, as well as international affiliate offices in Hamburg, London, Luxembourg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro, Dubai, and Hong Kong. H.I.G. specializes in providing both debt and equity capital to middle market companies, utilizing a flexible and operationally focused/value-added approach:

• H.I.G.’s equity funds invest in management buyouts, recapitalizations, and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.
• H.I.G.’s debt funds invest in senior, unitranche, and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets.
• H.I.G.’s real estate funds invest in value-added properties, which can benefit from improved asset management practices.
• H.I.G. Infrastructure focuses on making value-add and core plus investments in the infrastructure sector.

Since its founding in 1993, H.I.G. has invested in and managed more than 400 companies worldwide. The Firm’s current portfolio includes more than 100 companies with combined sales in excess of $53 billion. For more information, please refer to the H.I.G. website at hig.com.

*Based on total capital raised by H.I.G. Capital and its affiliates.

Contact:

Media Relations
[email protected]

H.I.G. Capital Hong Kong, Ltd.
Suite 3106, Level 31, Alexandra House
18 Chater Road, Central,
Hong Kong, China
Phone: +852 2707 5000
hig.com

Three general partners with operating exits behind them will pair capital with commerce infrastructure for the consumer brands they back.

LOS ANGELES, Aug. 31, 2026 — F&F Ventures, the venture capital arm of the Founders & Funders™ community, today launched a $10 million ecommerce fund in partnership with SHOPLINE, the global commerce platform serving more than 700,000 merchants worldwide. The fund invests from pre-seed through Series A in consumer brands and the technology behind them.

The fund is led by three general partners who built the kinds of companies it intends to back. Jeff Erickson, General Partner and Founder of Founders & Funders™, scaled a consumer brand to eight figures before its sale to a private equity firm, and has since invested in more than 40 companies as an angel investor. Adam Shaw, Co-Founder of Founders & Funders™ and General Partner, built a physical product company from zero to $18 million, led a seven-figure consumer goods brand, and brings global supply chain and private equity experience. Jian Tam, General Partner, is a serial CPG entrepreneur with multiple ecommerce exits and more than twenty years in the category, including Co-Founder of ProteinWaffles.com.

Deal flow comes through the Founders & Funders™ community, which has run more than 300 events in the US and internationally over the past eight years. Its VC ReversePitch™ series, in which investors pitch founders on their thesis and check size rather than the other way around, runs in several major cities this fall, starting in Denver on September 17 and including stops in San Francisco and LA for Tech Week by a16z.

The fund’s current portfolio spans 13 consumer brands, among them Protein Waffles, NoLimit, See Sea, Link Luggage, OnGo Energy, Board Budder, and G Box.

“As the venture capital arm of Founders & Funders, we are fully committed to increasing the likelihood of success for the companies we invest in. We are already seeing the impact we are able to make working with our portfolio companies by leveraging our network connections, distribution channels, eCommerce expertise, experience, and relationships,” said Jeff Erickson, General Partner of F&F Ventures.

Portfolio companies get SHOPLINE alongside the capital — storefront, payments, marketing automation, loyalty, and multi-channel selling running on one system. Christopher Yang, Co-President of SHOPLINE, serves on the F&F Ventures investment committee.

“F&F is putting capital and operating experience into these companies at the same time, and that combination is what actually moves a young brand,” said Yang. “Our part is making sure the commerce side is built as one system from day one, while the company is still early enough to get it right.”

About F&F Ventures

F&F Ventures is the venture capital arm of Founders & Funders™, investing pre-seed through Series A in consumer brands and the technology behind them. The firm originates its deal flow from Founders & Funders, the eight-year-old relationship engine for venture, with a massive network and events in 12 cities and four-plus countries, including its VC ReversePitch™ series. F&F Ventures pairs capital with operating support, giving portfolio companies the network, distribution, and commerce infrastructure that increase their likelihood of success. Learn more at fandf.vc.

About SHOPLINE

Founded in 2013, SHOPLINE is a leading global Software-as-a-Service (SaaS) provider and omnichannel commerce enabler. The platform empowers over 700,000 merchants worldwide to build, market, and scale their businesses through a comprehensive suite of unified commerce solutions, including e-commerce website creation, social commerce, live shopping, and point-of-sale systems. Headquartered in Singapore, SHOPLINE operates globally with a thriving partner ecosystem designed to level up retail operations for brands of all sizes. Learn more at www.shopline.com.  Follow us on LinkedIn.

Media Contact

David Wamsley
Rosebud Communications
[email protected]
415.259.9104

SOURCE SHOPLINE

This asset purchase brings the Omni Cyber Solutions Agentic Platform and its AI-powered security operations technology into the Athena Agentic portfolio, enhancing the Athena Unified Cyber Operations Platform’s vulnerability scanning, Shadow AI, and penetration testing capabilities.

DALLAS, Aug. 31, 2026 — Athena Agentic today announced the purchase of the Omni Cyber Solutions (OCS) Agentic Platform, an AI-powered cybersecurity platform. Under the asset purchase, Athena Agentic acquires the platform’s technology and intellectual property and will integrate its capabilities into the Athena Unified Cyber Operations Platform. This marks Athena Agentic’s second acquisition in under sixty days.

Omni Cyber Solutions earned its reputation building full security operations centers for some of the most demanding customers in the world, across the financial services, government, and enterprise sectors on multiple continents. That experience directly informs the practical design of the Agentic Platform.

The purchase positions Athena Agentic at the intersection of two forces reshaping cybersecurity: autonomous, machine-speed operations and the global demand for trusted, sovereign-ready security delivery. As adversary breakout times shrink to seconds and the average cost of a data breach surpasses $4.44 million, the ability to deploy, staff, train, and operate autonomous security operations anywhere in the world has become a board-level priority.

The Agentic Platform’s capabilities will be reimagined and integrated across the Athena Unified Cyber Operations Platform, enabling customers to move from fragmented tooling and manual staffing to unified, autonomous operations that can be deployed and scaled globally. Existing customers will continue to receive full product support and will gain access to enhanced capabilities as integration work progresses.

“Bringing our Agentic Platform to Athena Agentic opens a new chapter for the technology we built. We have always believed that world-class security operations should be within reach of every enterprise, not just the largest few. Now the platform has the home and the partners to reach global scale.”
— Brett Kelsey, Chief AI Officer, Athena Agentic

Terms of the asset purchase were not disclosed. The transaction is effective July 16, 2026.

About Athena Agentic

Athena Agentic pioneered the Unified Cyber Operations Platform (UCOP): the first platform to unify autonomous security operations, vulnerability management, AI governance, and GRC into a single intelligent ecosystem. Rather than forcing organizations to manage dozens of disconnected tools and siloed teams, UCOP breaks down operational barriers and enables every cyber function to operate as one coordinated system.

At Athena Agentic, we believe cybersecurity should be unified, autonomous, and always protecting. Our mission is simple: empower organizations to defend at machine speed while giving security leaders the visibility, intelligence, and confidence to focus on strategic decisions instead of operational noise.

Athena Agentic is the AI-native technology platform owned by Agentic Cyber AI, LLC.

SOURCE Athena Agentic

Strategic investors join as Diffraqtion caps its pre-seed with $10M total funding, following on-sky demonstrations, advancement under its DARPA program, and NASA awards in orbital debris tracking and orbital edge computing.

SOMERVILLE, Mass., Aug. 31, 2026 — Diffraqtion, an MIT and University of Maryland spinout building quantum camera platforms for defense and space sensing, today announced strategic investments from Lockheed Martin Ventures and Presidio Ventures, the venture arm of Sumitomo Corporation, bringing total funding to over $10M.

Following strong investor interest, Diffraqtion elected to cap its pre-seed, which also includes SBI US Gateway Fund with Plug and Play, Collaborative Fund, and TekVentures, with follow-on participation from existing investors Aether VC, milemark•capital, and ADIN.

The investment follows seven months of rapid progress since the round’s first close led by Ground State Ventures, announced in January 2026. The company completed on-sky demonstrations at a partner observatory, distinguishing closely spaced objects. Its DARPA Direct-to-Phase-II SBIR advanced into its second option period, and NASA has since selected Diffraqtion for an SBIR Phase I in orbital debris tracking and named the company winner of its $100,000 Space to Soil Challenge for adaptive sensing and onboard processing.

Diffraqtion’s quantum cameras resolve detail below the diffraction limit, the hard resolution floor that the aperture of a lens imposes on every conventional optical system. By sorting incoming light by its shape rather than its brightness, they measure information conventional cameras discard, reducing the aperture and compute needed to classify far-away objects. Company simulations indicate that the approach can resolve features up to 20 times smaller, and that onboard processing classifies targets orders of magnitude faster than conventional pipelines. The method is passive and draws on quantum estimation theory rather than quantum computing, without using qubits or cryogenics.

The new funding takes the technology into its first fielded camera, with flight heritage planned through a hosted payload on a partner spacecraft. To lead the effort, Diffraqtion has appointed Peter Kazlas as Head of Engineering. Kazlas brings 25 years of experience taking novel optics from lab bench to volume production, including at E Ink and QD Vision, acquired by Samsung.

“For as long as cameras have existed, seeing farther has meant building bigger optics,” said Johannes Galatsanos, CEO and Co-Founder of Diffraqtion. “Our cameras break that paradigm, delivering better mission capability at a fraction of the aperture, size, and cost. Now we’re building our first fielded camera and preparing for operational engagements in space domain awareness and reconnaissance.”

“What excites us about Diffraqtion is how they’re applying quantum-enabled imaging to extract more information from light and improve target detection and classification with smaller, more efficient sensing systems,” said Chris Moran, Vice President and General Manager of Lockheed Martin Ventures. “We invest in technologies with the potential to shape future mission capabilities, and this team’s rapid progress from laboratory development toward flight demonstration is particularly promising.”

“What drew us to Diffraqtion is that the same physics advantage applies whether the camera is observing the sky or the earth, or guiding a physical system,” said Ross Leav, SVP at Presidio Ventures. “As the venture arm of Sumitomo Corporation, we see significant opportunity to bring this capability to industrial and commercial markets globally, and we’re excited to support the team as they move into deployment.”

About Diffraqtion

Diffraqtion builds quantum camera platforms that let machines resolve detail beyond the limits of conventional optics, pairing photonic hardware with a proprietary model layer that turns raw imagery into real-time intelligence. The company is developing the technology for space domain awareness and reconnaissance, with applications across drones, autonomy, and precision inspection. Diffraqtion is an MIT and University of Maryland spinout headquartered in Somerville, Massachusetts.

Media Contact: [email protected] | www.diffraqtion.com 

SOURCE Diffraqtion

Ben Nager joins as a Partner with Counsel Shelley Azizi and paralegal John ‘Jack’ McCann.

NEW YORK, Aug. 31, 2026 — Norm Law LLP, an AI-native full-service law firm running on the Norm Ai platform, today announced the expansion of its Private Funds practice with the addition of Ben Nager, Shelley Azizi, and John ‘Jack’ McCann.

Nager joins Norm Law from Sidley Austin as a Partner to lead the firm’s Blue Sky filings and state securities regulatory capabilities within its Private Funds practice. He is joined by Counsel Shelley Azizi and paralegal Jack McCann, both former Sidley colleagues, bringing together an established team with deep experience managing state and federal securities filings for institutional investment funds.

“Ben, Shelley, and Jack bring an established practice grounded in detailed knowledge of securities requirements across all 50 states,” said Mike Schmidtberger, Chair of Norm Law and former Chair of the Executive Committee of Sidley Austin, “I worked with Ben and Shelley for many years and am glad to be reunited with them.”

Norm Ai has developed technology that incorporates jurisdiction-specific filing requirements, deadlines, fees, and other rules into a central workflow. The platform organizes fund and investor information, identifies upcoming obligations, flags missing or inconsistent data, and gives clients direct visibility into required actions and filing status. Norm Law attorneys remain responsible for reviewing the applicable rules, resolving legal questions, and completing filings with federal and state regulators.

“Norm Ai and Norm Law uniquely integrate world-class legal talent with the frontier of legal AI,” said John Nay, founder and CEO of Norm Ai. “Norm Ai embeds deep knowledge of the relevant laws and regulations into software that drives faster, more consistent outcomes for clients. This is exactly why we built an AI company and a full service law firm together.”

“Blue Sky work involves hundreds of jurisdiction-specific requirements, recurring deadlines, and large volumes of fund and investor data,” said Scott Worland, Chief Technology Officer at Norm Ai. “Our engineers built a platform that turns that complexity into a structured workflow. Clients submit information in one place, relevant obligations are surfaced automatically, and the legal team can focus on the exceptions and decisions that require judgment.”

Nager brings almost 30 years of experience advising investment banking and fund management clients on securities regulatory matters. He has coordinated Form D and state notice filings for hedge funds, commodity pools, and private equity funds and led large-scale, 50-state remediation projects involving registration and exemption issues. He has also helped obtain FINRA approval for hundreds of initial and secondary offerings by REITs, SPACs, banks, corporate issuers, commodity ETFs, and commodity pools.

Azizi joins Norm Law as Counsel, bringing 20 years of experience advising pooled investment funds, including hedge funds, private equity funds, REITs, and other private entities, on federal and state securities regulatory matters, with an emphasis on Regulation D offerings. McCann joins as a Paralegal, supporting the team’s Blue Sky and related securities filing work.

Clients representing more than $35 trillion in assets under management leverage Norm Ai. Norm Law uses the same technology to serve institutional clients as outside counsel. These additions expand Norm Law’s ability to support clients across private funds, securities regulation, technology transactions, intellectual property, M&A, and other high-stakes matters.

About Norm Ai

Norm Ai builds agentic law, embedding law into AI agents. Its systems help govern how AI operates in high-stakes, regulated environments across a client base representing more than $35 trillion in combined assets under management. Norm Ai also powers Norm Law, the first AI-native law firm built for institutional clients. Norm Ai has raised more than $260 million from Khosla Ventures, Craft Ventures, Bain Capital Ventures, Coatue, Blackstone, Vanguard, Citi, New York Life, TIAA, Henry R. Kravis, and Marc Benioff. For more information, visit norm.ai.

About Norm Law

Norm Law is the first AI-native full-service law firm. Norm Law’s model is designed to help its attorneys analyze those materials, identify issues, and move transactions forward efficiently while remaining focused on clients’ commercial objectives. It combines top-tier legal talent with AI agents powered by Norm Ai to deliver legal work with greater speed, consistency, and scale. For more information, visit normlaw.com.

Media Contact: [email protected] 

SOURCE Norm Law

SUZHOU, China, Aug. 31, 2026 — Convergen, a biotechnology company pioneering targeted protein degradation (TPD) therapies for diseases driven by pathological protein aggregates, today announced the closing of a $15 million Seed+ financing round. This round was led by MPCi, with participation from LAV, BioTrack Capital and a leading biotech fund. Prior to this round, the company raised $10 million in a seed financing round led exclusively by Qiming Venture Partners.

The proceeds will be used to further advance Convergen’s proprietary degrader platform and accelerate its pipeline for neurodegenerative disorders and other protein aggregation diseases.

“We are grateful to the distinguished group of investors and their confidence in our science, platform and team,” said Dr. Jinquan Sun, CEO of Convergen. “We have made significant progress in advancing our protein degradation platform. This financing will enable us to accelerate our lead asset toward the clinic while continuing to advance our pipeline, with the goal of bringing new therapeutic options to patients with neurodegenerative diseases and beyond.”

Addressing a Critical Unmet Need
Neurodegenerative diseases such as Alzheimer’s represent one of the largest unmet medical needs globally, with pathologic protein aggregation at the core. Convergen’s scientific founder Prof. Ting Han, whose laboratory reported the first TRIM21 molecular glue, established the proof-of-concept of the first TrimTAC degrader (November 2024 in Cell) which targets protein aggregopathies by exploiting TRIM21’s unique property. Beyond neurodegeneration, TrimTAC has demonstrated potential in selectively degrading other targets for autoimmune diseases.

MPCi said: 
“Convergen’s degrader platform is truly differentiated in the targeted protein degradation landscape. Matrix Partners China has long adhered to an investment philosophy of ‘investing early, investing in high barriers, and investing in differentiation,’ with a focus on the application potential of breakthrough technology platforms across disease areas. We are highly confident in the extensibility of Convergen’s original platform and in the team’s ability to translate scientific discovery into clinical drugs. We look forward to partnering with the company to advance novel therapeutic options to patients worldwide.”

About Convergen
Convergen is a biotechnology company pioneering the next-generation targeted protein degradation technology designed to selectively eliminate pathological protein aggregates. Founded to address the significant unmet medical needs in neurodegenerative disease and beyond, the company combines cutting-edge academic research with industry-proven drug development expertise.

SOURCE Convergen

Financing supports advancement of late-stage infectious disease pipeline, including Lonafarnib for the treatment of chronic hepatitis D

KIRKLAND, Wash., Aug. 31, 2026 — EIT Pharma, Inc. (“EIT Pharma” or the “Company”), a biotechnology company focused on developing therapies for infectious diseases, today announced the successful close of an oversubscribed $35 million Series A financing round. The round was led by Propel Bio Partners, with participation from Good Ventures, Arrowtown, and others.

The financing follows the U.S. Food and Drug Administration’s (FDA) acceptance of the New Drug Application (NDA) for lonafarnib for the treatment of chronic hepatitis D (CHD), a serious life-threatening liver disease caused by hepatitis D virus (HDV) in individuals who already have hepatitis B virus infection. Lonafarnib is an investigational first-in-class oral CHD therapy candidate with a unique mechanism of action. If approved, lonafarnib’s oral administration and room-temperature storage may offer practical advantages for people impacted by CHD and healthcare providers who consider quality of life, treatment burden, and accessibility when evaluating treatment options.

Proceeds from the funding will support continued FDA review activities related to lonafarnib, and future manufacturing and commercial readiness steps for lonafarnib, subject to regulatory approval. The funding will also assist with the advancement of EIT Pharma’s infectious disease pipeline and general corporate operations.

“This oversubscription of this round is a validation of EIT Pharma’s founding belief that advancing important medicines is about recognizing unrealized potential and assembling the scientific, clinical, regulatory, and commercial expertise to turn that potential into a treatment for patients,” said Dr. Leen Kawas, PhD, Chief Executive Officer of EIT Pharma. “This new capital allows us to continue advancing lonafarnib through the review process and, subject to FDA approval, prepare to bring it to patients.”

“EIT Pharma pairs a differentiated, late-stage asset with a team experienced in moving complex programs through development and regulatory review,” said Richard Kayne, General Partner of Propel Bio Partners. “We see meaningful value potential across EIT Pharma’s infectious disease pipeline, and we’re backing a management team with the scientific, clinical, and commercial discipline to realize it. We’re proud to support EIT Pharma at this pivotal stage as it works to bring important new therapies to underserved patient communities.”

About Lonafarnib

Lonafarnib is an investigational oral therapy candidate being evaluated for the treatment of chronic hepatitis D. Lonafarnib is designed to target a key step in the hepatitis D virus lifecycle and is currently the only oral therapeutic candidate in late-stage clinical development for chronic hepatitis D. Lonafarnib has not been approved by the U.S. Food and Drug Administration or any other regulatory authority for the treatment of chronic hepatitis D. The safety and efficacy of lonafarnib have not been established.

About EIT Pharma, Inc.

EIT Pharma is a biotechnology company focused on advancing therapies for infectious diseases with significant unmet medical needs. The company is developing a portfolio of programs designed to address serious infectious diseases through rigorous science, disciplined execution, and a patient-centered approach focused on translating scientific innovation into meaningful real-world impact for patients.

Forward-Looking Statements

This press release contains forward-looking statements regarding regulatory review timelines, anticipated milestones, potential product characteristics, and future development plans. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Lonafarnib is an investigational product candidate and has not been approved by the FDA. There can be no assurance that the FDA will approve the NDA or that the product will become commercially available. EIT undertakes no obligation to update forward-looking statements except as required by law.

Media Contact

Reevemark
Jacqueline Zuhse/Jill Steinman
[email protected]
212-433-4600

SOURCE EIT Pharma

Carrick provides liquidity for existing Limited Partners and reinforces long-term conviction in Saviynt while the security leader surpasses $300 million in ARR and launches Zuma, its enterprise AI identity security platform

SAN FRANCISCO and NEWPORT BEACH, Calif., Aug. 31, 2026 — Carrick Capital Partners (“Carrick”), a growth-oriented investment firm focused on operationally scaling B2B software and technology-enabled businesses, today announced the closing of a single-asset continuation vehicle (the “CV”) for Saviynt (the “Company”), a leading identity security company, with approximately $600 million in capital commitments. The transaction includes a new $255 million investment in the Company with meaningful participation from Carrick’s GPs, representing the largest investment in the firm’s history.

Coller Capital was the lead investor and HSBC Asset Management acted as co-lead investor in the new vehicle, which offered Carrick’s existing limited partners the option to roll their equity into the CV or realize a 11x gross multiple (10x net) on invested capital in Carrick’s initial investment. Carrick’s new investment was made as part of the final close of Saviynt’s Series B financing and helped fund a tender offer that provided liquidity to Company employees. Together, the transactions extend Carrick’s partnership with a proven platform and align the firm with Saviynt’s management team and new Series B investors in delivering long-term value.

The closing comes amid accelerating momentum at Saviynt. The Company recently announced that it has surpassed $300 million in annual recurring revenue, up from approximately $10 million at the time of Carrick’s initial investment. This year, Saviynt has grown bookings by more than 80% while maintaining a 96% customer retention rate. Saviynt also launched Zuma, its enterprise AI identity security platform, which gives organizations a unified control plane to discover, protect, and govern AI agents, LLMs, and non-human identities alongside the human workforce. Zuma extends the Saviynt Identity Cloud, which converges identity governance and administration, privileged access management, application access governance, and identity security posture management to secure every identity across an organization’s applications, data, and infrastructure. This momentum, and customers’ urgent focus on unified identity security as they deploy AI at scale, drove the Company’s $700 million Series B at a valuation of approximately $3 billion.

Carrick identified Saviynt through the firm’s thematic sourcing work in cybersecurity, and built a relationship with the founding team before they raised institutional capital. As Saviynt’s only institutional investor until their Series B, Carrick led the Company’s $35 million Series A and supported Saviynt’s growth with follow-on financings while partnering closely with management on leadership expansion, go-to-market, and board development through the firm’s ABV (Approach to Building Value).

“Our limited partners entrust us to source exceptional companies before others see them, concentrate behind our highest-conviction ideas, and build durable value through operating performance rather than financial engineering,” said Marc McMorris, Co-CEO of Carrick. “This transaction delivered on that promise, providing our LPs a meaningful realization alongside the choice to stay invested in the Company’s next chapter. The caliber of investors who backed the vehicle speaks to the strength of both Saviynt and the Carrick model,” added Co-CEO Jim Madden.

“We underwrote a simple thesis years ago: identity would become the control plane of enterprise security. The AI era has proven it. Enterprises cannot deploy AI they cannot trust, which makes identity security the business enabler for AI adoption at scale,” said Chris Wenner, Managing Director at Carrick and Saviynt board member. “Saviynt built the unified platform to govern every identity, human, non-human, and AI agent, and we are tripling down because we believe it will be the leader in unified identity.”

 “The defining security problem of the AI era is that enterprises are now accountable for AI agents and non-human identities that act at machine speed. The platform we have built solves this problem by providing visibility, protection, and governance,” said Sachin Nayyar, Founder and CEO of Saviynt. “Carrick has been our partner and shared our vision from our first institutional round when Saviynt was focused on cloud-native identity governance, through our evolution to address AI-era identity security. This capital commitment underscores their continuing conviction and strengthens our ability to move even faster for our customers.”

The new capital positions Saviynt to accelerate product development across the Identity Cloud and Zuma, extend its leadership in AI and agentic identity security, and deepen integrations with hyperscalers, SaaS platforms, and global systems integrators, while continuing to serve its blue-chip base of enterprise customers worldwide.

Robert W. Baird & Co. served as financial advisor to Carrick. Proskauer Rose LLP served as legal counsel to Carrick on the CV, and Latham & Watkins LLP served as legal counsel to Carrick on its new investment.

About Carrick Capital Partners

Headquartered in San Francisco and Newport Beach, Carrick Capital Partners is a growth-oriented investment firm that operationally scales B2B software and technology-enabled businesses. Carrick invests thematically in sectors where the firm has deep domain expertise, sourcing the majority of its investments through long-term, proprietary relationships with founders, and is frequently the first institutional capital in its portfolio companies. Through its ABV (Approach to Building Value), Carrick takes a concentrated approach and dedicates significant resources post-investment, partnering with management teams to drive growth, retention, and margin expansion through automation and AI enablement. For more information, please visit www.carrickcapitalpartners.com.

About Saviynt

Saviynt is the identity security platform built to secure the modern enterprise. The Saviynt Identity Cloud manages, secures, and governs access for human, non-human, and AI agent identities across an organization’s applications, data, and infrastructure, and with Zuma, its enterprise AI identity security platform, Saviynt helps organizations build, run, and scale AI with confidence. The world’s leading brands trust Saviynt to reduce risk, improve visibility, and support compliance while enabling business agility. For more information, please visit www.saviynt.com.

About Coller Capital

Coller Capital is a global leader in the secondary market for private assets, renowned for being a pioneer and innovator in the asset class. Founded in 1990, Coller provides investment and liquidity solutions to private market investors worldwide, and currently manages $55* billion in private equity, private credit, and other private market vehicles. With headquarters in London and offices across North America, Europe, and Asia-Pacific, our multinational team offers a truly global reach.

Coller has exclusively focused on secondary investing since inception and today boasts one of the largest dedicated investment teams in the asset class.

 Coller’s Private Wealth Secondaries Solutions (PWSS) business offers perpetual funds to eligible private wealth investors globally.

For more information, visit www.collercapital.com

*As at 31 March 2026

About HSBC Asset Management

HSBC Asset Management should be referred to either in full or as HSBC AM to avoid confusion with any other financial services firms.

HSBC Asset Management, the investment management business of the HSBC Group, invests on behalf of HSBC’s worldwide customer base of retail and private clients, intermediaries, corporates and institutions through both segregated accounts and pooled funds. HSBC Asset Management connects HSBC’s clients with investment opportunities around the world through an international network of offices in 20 countries and territories, delivering global capabilities with local market insight. As at 30 June 2026, HSBC Asset Management managed assets totalling US$928bn (excluding HSBC Jintrust Fund Management Company Limited) on behalf of its clients.

For more information see http://www.global.assetmanagement.hsbc.com 

HSBC Asset Management is the brand name for the asset management businesses of HSBC Holdings plc.

Media Contact
Machie Madden
[email protected]
917.868.2358

Disclosures: This press release is provided for informational purposes only and is not an offer to sell, or a solicitation of an offer to buy, securities or interests in any fund managed by Carrick Capital Partners. Past performance, including the gross multiple on invested capital referenced herein, is not indicative of future results. Gross performance figures do not reflect the deduction of management fees, carried interest, or other expenses, which would reduce returns to investors. The statements quoted above from persons who are not clients of Carrick were made without compensation and reflect solely their own opinions and experience with Carrick. Portfolio company executives may be subject to certain conflicts of interest. Carrick Capital Partners is an investment adviser registered with the U.S. Securities and Exchange Commission; registration does not imply a certain level of skill or training.

SOURCE Carrick Capital Partners

Funding will accelerate pilot-scale production of lithium-6 and lithium-7 isotopes, strengthening a critical domestic supply chain for next-generation energy technologies.

SANTA FE, N.M., Aug. 31, 2026 — Molten Salt Solutions, Inc. (MSS), a New Mexico-based company with a novel large-scale production method for enriching lithium, announced the closing of an oversubscribed $7 million round of seed funding. The round was led by Dolby Family Ventures with participation from Vanedge Capital Partners, Alumni Ventures, Gaingels, True Ventures, and Future Ventures. 

Fusion systems require large, reliable supplies of enriched lithium-6. Lithium-7 is used in advanced fission molten salt reactors. Currently, the United States lacks commercial-scale production of either isotope, making rebuilding the secure, domestic source of both isotopes a recognized national priority for energy security. 

“Fusion and small modular fission reactors are racing toward commercialization and are necessary to meet growing global power demands. Both depend on a secure domestic supply of enriched lithium. MSS meets this need,” said John Elling, CEO of Molten Salt Solutions. “This investment enables us to scale our technology and production capability to meet the demands of advanced reactors today and in the future.”

The financing will accelerate MSS’s transition from laboratory-validated technology to pilot-scale production fulfilling active customer agreements, expand the technical and operations teams, and deepen partnerships across the fusion and advanced nuclear supply chain. The company is also advancing a broader portfolio of enriched isotopes to serve emerging markets. 

This raise follows MSS’s $3 million pre-seed and more than $5 million in grant funding, including support through New Mexico’s Advanced Energy Award. 

About Molten Salt Solution: Molten Salt Solutions, Inc. (MSS) is a New Mexico based company producing enriched stable isotopes for fusion and the advanced nuclear market. Founded by serial entrepreneurs and isotope enrichment leaders from Los Alamos National Laboratory, MSS has developed a proprietary platform that is 100X more efficient than legacy enrichment approaches. MSS is building a secure domestic supply of high-purity lithium-6 and lithium-7 for the fusion and advanced-nuclear sectors, alongside a growing portfolio of enriched isotopes for advanced technologies. Learn more at https://moltensaltsolutions.com; [email protected]. 

About Dolby Family Ventures: Dolby Family Ventures (“DFV”) is an early-stage venture capital firm. Founded in 2014, DFV formalizes the Dolby family’s ongoing, multi-generational commitment to Ray Dolby’s legacy of discovering and supporting visionary entrepreneurs. DFV focuses on seed and pre-seed investments across a range of science- and technology-driven sectors, including climate, robotics and automation, aerospace, digital innovation, and compute, as well as on disease-modifying treatments in neurodegeneration and neuropsychiatry. Advanced energy solutions has been an active area of investment for the firm over the past decade, having made over 10 investments since 2016 supporting this thesis. DFV is not affiliated with Dolby Laboratories, Inc. For more information, visit www.dolbyventures.com. 

About Vandege Capital: Vanedge Capital is an early-stage venture capital fund based in Vancouver, Canada. Founded in 2010, the firm partners with founders solving hard technology problems across energy, advanced materials, computing, artificial intelligence, computational biology, and defense. Notable investments include SpaceX, Echodyne, Mojo Vision, Canalyst, and Raxium. For more information, visit vanedgecapital.com.

About Alumni Ventures: Alumni Ventures is one of the most active venture firms in the world, making startup investing more accessible for individuals. Powered by an 850,000+ member network of alumni, founders, experts, investors, and subscribers, AV co-invests alongside leading firms like Andreessen Horowitz, Sequoia, and NEA. The firm regularly invests in the nuclear and broader energy sectors, backing companies such as Pacific Fusion, X-Energy, Aalo Atomics, Radiant Nuclear, Thea Energy, Realta Fusion, and Valar Atomics.

Since its founding in 2014, Alumni Ventures has raised over $1.6 billion from over 25,000 Investors and Syndicate Members, and invested in 1,800+ companies across every major sector and stage. The firm has been named one of PitchBook’s most active U.S. venture firms every year since 2018, and was ranked #20 in Time Magazine’s list of America’s Top Venture Capital Firms of 2025. Learn more at av.vc.

About Gaingels: Gaingels is amongst the largest investors in the world aiming to show the world that equity of access and representation in venture capital delivers positive returns. Learn more at https://gaingels.com/.

About True Ventures: True Ventures is a Silicon Valley venture capital firm that is first to believe in brilliant founders and invests in them at the earliest stages, when partnership matters most. Founded in 2005, the firm manages $4 billion in committed capital across over 450 teams spanning AI, software, hardware, cybersecurity, consumer, digital biology, and more. Notable investments include Enveda, Iceye, Handshake, Basecamp Research, Peloton, Duo Security, Ring, HashiCorp, and more. For more information visit www.trueventures.com.

About Future Ventures: Future Ventures is an early-stage venture capital firm investing in frontier technologies that have the potential to transform industries and address some of the world’s most consequential challenges. Founded in 2018, the firm manages over $1.4B in committed capital and partners with visionary founders at the earliest stages, focusing on breakthrough science and engineering across energy, advanced computing, AI, biotechnology, aerospace, robotics, novel chemistry, and beyond. Future Ventures has a long-standing focus on advanced energy, with investments spanning fusion, next-generation nuclear, energy storage, critical materials, and other technologies aimed at enabling abundant, reliable, and sustainable energy. Notable investments include Commonwealth Fusion Systems, Realta Fusion, Subcritical Systems, and Red Metals. For more information, visit future.ventures.

SOURCE Molten Salt Solutions